Here is the private companies website for easy access: https://www.aucentra.com/
Like others have said, it doesn't look like a cell (car-t) therapy, rather, they hoping to inhibit the CDK4/6 signalling pathway while using the auceliciclib with a commonly used chemotherapy drug Temozolomide.
CHM-The only ASX listed CAR-T comp with 2/3 human trials, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.747M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $27.16K | 8.958M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 66853948 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 94845096 | 28 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |